NASDAQ:ICPT Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Intercept Pharmaceuticals, Inc.
An investor, who purchased NASDAQ:ICPT shares, filed a lawsuit over alleged violations of Federal Securities Laws by Intercept Pharmaceuticals, Inc
View full press release